Kisa 346a1fb58e feat: Signal CGM strategic analysis + asset sale package

Adds complete go-to-market analysis for Signal CGM asset sale:

Analysis/
  - signal-cgm-segment-scoring-v1.md   (3-model scoring across 7 segments)
  - signal-cgm-re-scored-composite-v2.md (50/30/20 composite, MA+Medicaid scope)
  - signal-cgm-final-ranking-leverage-v3.md (final 4-segment rank + leverage map)

Assets/
  - signal-cgm-pitch-v1-plain.md       (plain language leave-behind)
  - signal-cgm-pitch-v2-professional.md (professional leave-behind)
  - master-summary.md                   (rankings, metrics, next-steps prompt)

Key findings: 25.2% CGM improper payment rate; 20% net revenue loss;
63% of denied claims permanently written off; billing company #1 target
for pilot; NikoHealth #1 for asset sale.

Co-Authored-By: Claude Sonnet 4.6 <noreply@anthropic.com>

2026-04-19 20:37:18 -04:00

4.8 KiB

Raw Blame History

Signal CGM — Asset Sale Overview

Plain Language Edition

SIGNAL CGM Stop Losing 20% of Your Clients' CGM Revenue. A ready-to-deploy tool for DME billing companies. STTIL Solutions LLC | kisasttil@gmail.com

The Problem. In Plain English.

Right now, your clients are losing money they don't have to lose.

For every $100 they bill on CGM (continuous glucose monitors), about $20 disappears. It doesn't go to fraud. It doesn't go to bad patients. It goes to paperwork that wasn't ready on time.

A claim gets denied. The product was already shipped. The patient has it. Your client can't get it back. They try to appeal. Most of the time, they lose more money fighting it than they get back.

Here's the part that stings: 94% of those denied claims could have been prevented. The information existed. Someone just didn't have it in hand before the order shipped.

That's what Signal CGM fixes.

What Goes Wrong — and When We Catch It

There are six places in the workflow where a claim goes from "fine" to "denied." We catch all six before the product ships, not after.

1. Prior Authorization — the biggest one. No PA before shipment = no money, period. No appeals, no second chances. We make sure PA is confirmed 45 days before the order goes out the door.

2. The Coverage Clock. Every CGM patient has a refill schedule. We track it for every patient, every month. This is the engine everything else runs on.

3. The 6-Month Doctor Visit. Medicare requires a check-in with the prescribing doctor every 6 months for CGM patients to keep getting supplies. When that visit doesn't happen, the claim gets denied. We flag it a month before it becomes a problem.

4. Prescriber Enrollment Check. If the doctor who ordered the CGM isn't currently enrolled in Medicare, the claim gets denied — even if everything else is perfect. We re-check this every time an order is about to ship, not just when the patient first signs up.

5. New Patient Setup. Before anyone's first order ships, we check eligibility, duplicate claims, and whether the right supplier is on file with CMS. Bad setups become expensive surprises later.

6. Audit Defense — the safety net. Every check we run gets logged with a time stamp. If CMS ever audits one of your clients, that log shows exactly what was verified and when. It's proof they were doing things right.

Try It First. On Your Own Client Data.

We're offering a 60-day pilot at no cost.

Pick two to three of your suppliers. We run Signal CGM on their live CGM patient data. We track what would have been denied. We show you what changed.

At the end of 60 days, you'll see the before-and-after in your clients' actual numbers — not in a demo, not in a made-up scenario.

If it doesn't show a clear improvement in first-pass CGM claims, there's no deal.

What We're Asking

Signal CGM is available two ways:

Option 1 — You own it. One-time purchase: $45,000–$65,000. You get the full code, all the research, 30 days of live handoff sessions, and the AI development context so your team can keep building. You white-label it. You charge your clients. The revenue is yours.

Option 2 — Per-client licensing. $75 per supplier client per month. If you have 20 CGM-active clients, that's $1,500/month. You pass the cost through at whatever margin makes sense for your business.

Three Questions You're Probably Already Thinking

"Is this worth the cost?" Your clients are losing $20 of every $100 they bill on CGM. If Signal CGM moves that to $14 lost instead of $20 — a modest improvement — a single 500-patient supplier recovers $9,000+ per month. At $75/month, that's a 120-to-1 return. The cost question answers itself.

"Doesn't this make my billing services less necessary?" No. Your clients still need you to run their billing, handle denials, and manage payer relationships. Signal CGM handles the pre-shipment window — the 45 days before a claim exists. That's not your current job. It becomes a new service you offer, not a replacement for what you already do.

"What happens to patient data?" Signal CGM never stores patient names, Social Security numbers, dates of birth, or contact information. The only identifier the system uses is the supplier's internal patient ID number. All audit logs hash even that. Data stays on your infrastructure, not ours. A Business Associate Agreement is part of every deployment.

Ready to run the pilot? Contact: kisasttil@gmail.com STTIL Solutions LLC | Signal CGM

Key data: CMS 2024 CGM improper payment rate 25.2% / $278.5M projected annual. Source: CMS Glucose Monitoring Compliance

4.8 KiB Raw Blame History Unescape Escape